News & Analysis on Clinical Trial Services & Contract Research And Development
Pharma finance
QuintilesIMS may potentially divest its contract sales business – which would improve the company’s overall profitability and enable it to focus on growing other aspects of the organization.
Avista Pharma Solutions, Inc. has been contracted to manufacture an opioid-derived small molecule, which is a component of a conjugate vaccine being developed to treat opioid addiction.
The EMA has cleared Janssen to make the HIV drug Prezista (darunavir) using a continuous manufacturing (CM) process as well as the previously approved batch method.
DIA 2017
CROS NT has announced a new clinical trial solution that enables sponsors to take a risk-based approach to site monitoring – a shift to which is driving company growth, says CEO.
Evotec has joined a consortium through which it gains access to a sample biobank in order to perform drug discovery based on unique kidney disease patient cohorts.
Zynerba Pharmaceuticals Inc has begun a Phase I trial of cannabinoid patch it is developing for fibromyalgia and peripheral neuropathic pain.